4//SEC Filing
Martin James Joseph 4
Accession 0001493152-26-002036
CIK 0001412486other
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 4:10 PM ET
Size
6.3 KB
Accession
0001493152-26-002036
Insider Transaction Report
Form 4
Martin James Joseph
Co-CEO and CFO
Transactions
- Award
Stock Options (Right to Buy)
[F1]2026-01-09+49,229→ 49,229 totalExercise: $1.10Exp: 2036-01-09→ Common Stock (49,229 underlying)
Footnotes (1)
- [F1]The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Compensation Committee of the Board of Directors. The non-qualified stock options are granted under the Issuer's 2025 Equity Incentive Plan and the exercisability shall be subject to execution of the Issuer's form of Non-Qualified Stock Option Agreement. The non-qualified stock options shall vest as follows: one-half shall vest and become exercisable on January 9, 2027 and the remaining half shall vest and become exercisable in eight equal quarterly installments commencing on March 31, 2027, subject to the Reporting Person continuing to serve as an officer of the Issuer on each applicable vesting date.
Signature
/s/ James Martin|2026-01-13
Documents
Issuer
Cocrystal Pharma, Inc.
CIK 0001412486
Entity typeother
Related Parties
1- filerCIK 0001510224
Filing Metadata
- Form type
- 4
- Filed
- Jan 12, 7:00 PM ET
- Accepted
- Jan 13, 4:10 PM ET
- Size
- 6.3 KB